Amin Otmani

About me

Amin received his Masters degree in 2012 in Immunology and Development from Aix-Marseille University, France before training in the lab of Prof. Frederick W. Alt at Harvard Medical School and Prof. Qiang Pan-Hammarström at Karolinska Institutet where he focused on genomic instability in hemopathies. In 2018 he completed his Medical degree from Aix-Marseille University. Amin joined the Pete Williams Lab in 2019 to focus on mitochondrial and metabolic changes in glaucoma and to explore different options to modulate these.

Article: ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2024;12(1):37
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume
Otmani A; Johannesson G; Brautaset R; Tribble JR; Williams PA
Article: REDOX BIOLOGY. 2021;43:101988
Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction
Tribble JR; Otmani A; Sun S; Ellis SA; Cimaglia G; Vohra R; Joe M; Lardner E; Venkataraman AP; Dominguez-Vicent A; Kokkali E; Rho S; Johnnesson G; Burgess RW; Fuerst PG; Brautaset R; Kolko M; Morgan JE; Crowston JG; Votruba M; Williams PA
Article: TRANSLATIONAL VISION SCIENCE & TECHNOLOGY. 2021;10(1):22
When Is a Control Not a Control? Reactive Microglia Occur Throughout the Control Contralateral Pathway of Retinal Ganglion Cell Projections in Experimental Glaucoma
Tribble JR; Kokkali E; Otmani A; Plastino F; Lardner E; Vohra R; Kolko M; Andre H; Morgan JE; Williams PA
Article: TRANSLATIONAL VISION SCIENCE & TECHNOLOGY. 2021;10(1):21
Retinal Ganglion Cell Degeneration in a Rat Magnetic Bead Model of Ocular Hypertensive Glaucoma
Tribble JR; Otmani A; Kokkali E; Lardner E; Morgan JE; Williams PA